With the largest number of merger and acquisitions (M&As) happening in India in the pharmaceutical and healthcare sector, India is fast becoming a global hub for all pharmaceutical manufacturing, research, and generics.
The health and life sciences industry is fast paced, challenging and innovative. Our global presence help us to meet these challenges for our clients involved in cross-border transactions.
We regularly advise our clients on all the following complex business issues:
- Government regulatory compliance
- Licensing, collaboration, research & development
- Mergers and acquisitions
- Joint ventures
- Intellectual Property
- Fund investment projects
- Real Estate transactions
- Competition & international strategies
- Environmental regulation
- Employment and pensions
- Clinical trials
- Reclassification of drugs
- Product liability
- Health & safety
- High value disputes, judicial reviews and cross-border litigation
Aishwarya Lifesciences retains India Juris
India Juris advises US based Moringo Organics
India Juris advises Protech Biosystems on acquisition of Alchemy Medicine
IJ concludes US$ 5 mn transaction in wellness & healthcare sector.